Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
euglena CoTSE:2931 -1.13%64 EBITDA Margin % is 26.13% as of Dec. 2025, which is 795% above its 10-year median of 2.92. GuruFocus rates TSE:2931 with a GF Score™ of 64/100 and a GF Value™ of 円501.49 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,956 Consumer Packaged Goods companies, euglena Co ranks better than 63.91% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. euglena Co's EBITDA for the
three
months ended in Dec. 2025 was 円3,471 Mil. euglena Co's Revenue for the
three
months ended in Dec. 2025 was 円13,284 Mil. Therefore, euglena Co's EBITDA margin for the quarter that ended in Dec. 2025 was 26.13%.
euglena Co (TSE:2931) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
euglena Co EBITDA Margin % Related Terms
euglena Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for euglena Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2931 vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, euglena Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
euglena Co EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, euglena Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where euglena Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
euglena Co (TSE:2931) has a EBITDA Margin % of 26.13% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on euglena Co and its competitors. This is 795% above median its historical median of 2.92. According to the industry distribution chart, euglena Co ranks #706 out of 1956 companies in the Consumer Packaged Goods industry, placing it in the top 36.1%.
Is euglena Co's EBITDA Margin % too high?
euglena Co's current EBITDA Margin % of 26.13% is 795% above median its 10-year median of 2.92. The Consumer Packaged Goods industry median EBITDA Margin % is 9.01. euglena Co's value of 26.13% is 190.2% above this industry median. Based on the distribution chart, euglena Co ranks #706 out of 1956 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, euglena Co has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does euglena Co's EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, euglena Co ranks #706 out of 1956 companies for EBITDA Margin %. This puts euglena Co in the upper half of its industry. The industry median EBITDA Margin % is 9.01. euglena Co's value of 26.13% is 190.2% above this benchmark. While the company's 10-year median is 2.92 vs. the industry median of 9.01, euglena Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 9.01, based on 1,956 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. euglena Co's current EBITDA Margin % of 26.13% is 190.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on euglena Co and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 9.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. euglena Co's current EBITDA Margin % is 26.13%, which is 795% above median its own 10-year median of 2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is euglena Co stock overvalued right now?
Based on GuruFocus' analysis, euglena Co (TSE:2931) is currently considered Possible Value Trap. The stock's GF Value™ is 円501.49, compared to a current price of 円351.00 — trading 30% below its estimated fair value. The current EBITDA Margin % is 26.13%, which is 795% above median its 10-year median of 2.92 and 190.2% above the Consumer Packaged Goods industry median of 9.01. euglena Co's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For euglena Co (TSE:2931), the current EBITDA Margin % is 26.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is euglena Co (TSE:2931) Overvalued in 2026?
Based on GuruFocus' analysis, euglena Co stock appears to be undervalued.
The current stock price of 円351.00 is trading 30% below its estimated GF Value™ of 円501.49.
GuruFocus considers euglena Co to be Possible Value Trap.
Key valuation signals for TSE:2931:
EBITDA Margin %: 26.13% (795% above median its 10-year median of 2.92)
GF Value™: 円501.49 vs. price of 円351.00 (30% below fair value)
Industry Position: 190.2% above the Consumer Packaged Goods median (#706 of 1956)
No single metric tells the full story. See the TSE:2931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
euglena Co Ltd is a biotechnology company that researches, develops, produces, and markets microalgae. The company focuses on commercializing its algae research for a variety of uses, including functional foods and cosmetics. Euglena also researches ways to use its microalgae for carbon capture and biofuel production. The company operates in three segments: Healthcare Business, Biofuel Business, and Other Businesses.
64GF Score
Get the complete analysis for TSE:2931
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2931 has been successfully added to your 
